Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicentric and Prospective Clinical Trial to Check the Cost-effectiveness of Corifollitropin Alfa vs. Recombinant FSH and/or HP-hMG

NCT02213627 is registered in ClinicalTrials.gov with IVI Madrid as lead sponsor.

NCT NCT02213627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02213627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicentric and Prospective Clinical Trial to Check the Cost-effectiveness of Corifollitropin Alfa vs. Recombinant FSH and/or HP-hMG
Lead sponsor
IVI Madrid
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2014
Completion date
December 31, 2015
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female reproductive problem, infertility